Yeda Chen
Impact in
-
- Cancer-related molecular mechanisms research
-
- Bioinformatics and Genomic Networks
Papers in
-
- Kidney Stones and Urolithiasis Treatments 3
- Renal cell carcinoma treatment 3
- Oncology 3
- Cancer Immunotherapy and Biomarkers 1
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Shaoqi Rao (3 shared papers)Xiaolei Zhao (3 shared papers)Xiaoyu Zuo (1 shared paper)Manqiong Yuan (1 shared paper)Xiaolu Duan (6 shared papers)Guohua Zeng (5 shared papers)Tuo Deng (3 shared papers)Wenqi Wu (3 shared papers)
In The Last Decade
Yeda Chen
21 papers receiving 280 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 23
- Molecular Biology 107
- Pulmonary and Respiratory Medicine 44
- Genetics 31
- Computer Vision and Pattern Recognition 24
Countries citing papers authored by Yeda Chen
This map shows the geographic impact of Yeda Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeda Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeda Chen more than expected).
Fields of papers citing papers by Yeda Chen
This network shows the impact of papers produced by Yeda Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeda Chen. The network helps show where Yeda Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yeda Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 109 | |
| 2 | 2019 | 25 | |
| 3 | 2025 | 22 | |
| 4 | 2018 | 21 | |
| 5 | 2018 | 18 | |
| 6 | 2020 | 16 | |
| 7 | 2020 | 16 | |
| 8 | 2021 | 15 | |
| 9 | 2023 | 12 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 8 | |
| 12 | 2016 | 7 | |
| 13 | 2020 | 5 | |
| 14 | Mitochondrial phosphoenolpyruvate carboxykinase inhibits kidney renal clear cell carcinoma malignant progression, leading to cell energy metabolism imbalance. | 2023 | 4 |
| 15 | 2019 | 3 | |
| 16 | 2023 | 3 | |
| 17 | 2016 | 2 | |
| 18 | 2024 | 2 | |
| 19 | 2025 | 2 | |
| 20 | Association of genetic polymorphisms in leptin and leptin receptor with coronary artery disease in southern Chinese Han population. | 2016 | 1 |
About Yeda Chen
Yeda Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Genetics and Surgery, having authored 22 papers that have together received 301 indexed citations. Recurring topics across this work include Kidney Stones and Urolithiasis Treatments (3 papers), Genetic Associations and Epidemiology (3 papers), Renal cell carcinoma treatment (3 papers), Lipoproteins and Cardiovascular Health (2 papers), Bioinformatics and Genomic Networks (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Testicular diseases and treatments (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Cancer Research (23 citations), Molecular Biology (107 citations), Pulmonary and Respiratory Medicine (44 citations), Genetics (31 citations) and Computer Vision and Pattern Recognition (24 citations). Yeda Chen has collaborated with scholars based in China and Germany. Frequent co-authors include Shaoqi Rao, Xiaolei Zhao, Xiaoyu Zuo, Manqiong Yuan, Xiaolu Duan, Guohua Zeng, Tuo Deng, Wenqi Wu, Wei Zhu and Qingfeng Yu. Their work appears in journals such as Domestic Animal Endocrinology, Gut Pathogens, Clinica Chimica Acta, Clinical and Experimental Medicine and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.